CASI PHARMACEUTICALS, INC. Selling and Marketing Expense
CASI PHARMACEUTICALS, INC. (CASIF) reported Selling and Marketing Expense of $18.34 million for the 12-month period ending 2025-12-31, per its 20-F filed 2026-05-15.
Financial Statements › Expense Statement › Operating Expenses
us-gaap:SellingAndMarketingExpense · last filed 2026-05-15
| Period end | Selling and Marketing Expense 12 month |
|---|---|
| 2025-12-31 | $18.34M 20-F · filed 2026-05-15 |
| 2024-12-31 | $17.87M 20-F · filed 2026-05-15 |
| 2023-12-31 | $16.45M 20-F · filed 2026-05-15 |
| 2022-12-31 | $14.33M 20-F · filed 2025-03-31 |
| 2021-12-31 | $14.71M 20-F · filed 2024-03-28 |
| 2020-12-31 | $7.82M 20-F · filed 2023-04-26 |